These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7707100)

  • 1. Implications of the p53 tumor-suppressor gene in clinical oncology.
    Chang F; Syrjänen S; Syrjänen K
    J Clin Oncol; 1995 Apr; 13(4):1009-22. PubMed ID: 7707100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 gene mutations: case study of a clinical marker for solid tumors.
    Liu MC; Gelmann EP
    Semin Oncol; 2002 Jun; 29(3):246-57. PubMed ID: 12063677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumourigenesis associated with the p53 tumour suppressor gene.
    Chang F; Syrjänen S; Tervahauta A; Syrjänen K
    Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of genetic instability by gain-of-function p53 cancer mutants.
    Xu Y
    Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in p53 research and cancer treatment.
    Suzuki K; Matsubara H
    J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
    Harris CC
    J Natl Cancer Inst; 1996 Oct; 88(20):1442-55. PubMed ID: 8841019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressor p53: implications for tumor development and prognosis.
    Kirsch DG; Kastan MB
    J Clin Oncol; 1998 Sep; 16(9):3158-68. PubMed ID: 9738588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and human cancers.
    Lane DP
    Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 tumour suppressor gene.
    Steele RJ; Thompson AM; Hall PA; Lane DP
    Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of alterations in p53 expression in gynaecological neoplasms.
    Manek S; Wells M
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):52-5. PubMed ID: 8777259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for screening tumors for p53 status and therapeutic exploitation.
    Tullo A; D'Erchia AM; Sbisà E
    Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.